ABSTRACT
INTRODUCTION
The U.S. Centers for Disease Control and Prevention (CDC) estimated that approximately 79 million Americans have human papillomavirus (HPV), with an incidence of 14 million new cases annually. 1 The CDC stated that HPV infection "is so common that most sexually-active men and women will get at least one type of HPV at some point in their lives". 1 While HPV infection does not cause complications in every case, it is linked to genital warts and several types of cancer, including cervical, vulvar, vaginal, penile, anal, and oropharyngeal. 2 In 2013, Kansas tied for last among U.S. states for the lowest rate of HPV vaccination completion. 3 By county, HPV vaccination completion rates among 11 -18 year old adolescents ranged from 3% to 48%. 4, 5 For females in that age range, the HPV vaccination rates by county ranged from 4% to 58%, 5, 6 and for males in the same age range, 1% to 42%. 5, 7 According to the National Immunization Survey-Teen (NISTeen), 8 Kansas females and males 13 -17 years of age consistently ranked low among the 50 U.S. states for receiving at least one, two, and three doses of the HPV vaccine, and for being up-to-date with recommended vaccination series ( Table 1 and Table 2 ). Since 2006, HPV vaccines have been available in the U.S. 9 Both females and males can begin receiving an HPV vaccine at age nine, with early vaccination recommended so that recipients develop immunity prior to potential exposure. 10 As of 2016, a two-dose series was approved for children younger than 15 years. While the HPV vaccine can prevent HPV infection, genital warts, and associated cancers, it often is met with feelings of hesitance, fear, and aversion. Studies of online and social media communities resulted in a range of results, from mostly positive attitudes toward the vaccine 11, 12 to negative attitudes 13 to being more evenly divided. 14 The presence of negative HPV vaccine-related internet posts are of particular importance, as they can lead to negative perceptions about the vaccine and can encourage audiences to post negative messages, whereas positive messages appear to not encourage positive perceptions and positive message sharing. 15, 16 The influence of social media messages on guardian decisionmaking to get their children the HPV vaccine, especially in a specific geographical context, is not well-studied. Considering that 88% of U.S. adults use the internet and 79% use social media, 17 it is estimated that 1.9 million Kansas adults are internet users and 1.5 million use social media. 18 Thus, social media messages about HPV and the HPV vaccine likely influence statewide HPV vaccination rates.
The purpose of this study was to evaluate how Kansas guardians of children ages 9 -17 perceive HPV and the HPV vaccine, perceive social media messages about HPV and HPV vaccines and, in turn, assess how those messages influence their own perceptions about getting their children vaccinated against HPV. 21, 22 concepts. Unless noted, these outcome measures were indicated on 6-point Likert scales, ranging from "1 -strongly disagree" to "6 -strongly agree".
Source and social media use items asked participants their main source of learning about HPV and the HPV vaccine, which social media accounts they use, if any, if they follow health-related pages, and if they had seen, searched for, or posted about HPV and HPV vaccine-related information on social media.
Perceptions about HPV and HPV vaccine-related social media messages were based on health belief model 19, 20 and social amplification of risk framework 21, 22 concepts. Unless noted, these outcome measures were indicated on 6-point Likert scales, ranging from "1 -strongly disagree" to "6 -strongly agree". Statistical Analysis. Descriptive statistics were used to report participant demographic characteristics, demographic characteristics of their children aged 9 -17 years, and the HPV vaccination status of those children. Descriptive statistics were employed to report HPV and HPV vaccine perception items. Pearson correlation analyses, along with reliability statistics (Cronbach's alpha) were conducted to develop scales. Linear regressions were used to compare scales. Correlation analyses were conducted to test for relationships between participant demographic characteristics and perception items. ANOVA analyses were used to test relationships between participant demographic group characteristics and perceptions.
Descriptive statistics were calculated for source and social media use items. A one-sample t-test was used to calculate perceptions of social media depiction of the HPV vaccine.
Descriptive statistics were calculated for items about perceptions of HPV and HPV vaccine social media messages. Pearson correlation analyses, along with reliability statistics (Cronbach's alpha) were conducted to develop scales. Paired-samples t-tests compared participants' personal perceptions of HPV and the HPV vaccine to their perceptions of social media messages about HPV and the HPV vaccine. Independent samples t-tests (grouped by whether they had seen related information) and one-sample t-tests were performed to compare participants' perceptions about HPV and the HPV vaccine on social media.
Statistical analyses were performed using Qualtrics 23 and SPSS for Windows, Version 25.0. 24 For all Likert scale items, "I don't know" responses were treated as missing cases and not calculated in the analysis. The number of responses that were calculated are reported.
RESULTS

Participants.
Of the 233 people who began the survey, 73 participants were ineligible (screener questions ended the survey for participants who indicated that they did not: consent, currently reside in Kansas, or were not the guardian of at least one child aged 9 -17 years). Of the remaining 160 eligible participants, 95 had heard of HPV and the HPV vaccine and completed the survey for a participation to completion rate of 41.6%. Most of the participants were female, identified as mothers, belonged to Generation X, were White, non-Hispanic/LatinX, with two-or four-year college degrees, and an annual household income of under $100,000. Most of the participants resided in the Kansas City Metro area and Northeast Kansas. The demographic characteristics of the participants are shown in Table 2 .
HPV/HPV VACCINE AND SOCIAL MEDIA continued. Participants' Children. The participants reported having one to four children (M = 1.70, SD = 0.70), aged 9 -17 years. Most of these children were female, with a median age of 13 years. Most of the participants reported having conversations about the HPV vaccine with their children. Most of the participants also reported that a healthcare provider had spoken to them about vaccinating most of their children. However, most children had not been vaccinated against HPV. The median age of vaccinated children was 14 years, and the median age of unvaccinated children was 11 years. Among the unvaccinated children, parents most often reported that they definitely planned to get their children vaccinated before the child turns 18. The demographic characteristics and the HPV vaccination status information about the participants' children ages 9 -17 years are shown in Table 3 . Definitely not 19 (20.4) Tests for significant relationships between guardian demographics (generation, race, ethnicity, education, income, and region of residence) and child vaccination status (receiving at least one dose, no dose) show that children of guardians reporting an annual household income of $100,000 or more were significantly more likely to have received at least one dose of the HPV vaccine, compared to children of guardians with annual household incomes of less than $100,000 (p = 0.003). All other relationships were found to be statistically insignificant.
HPV and HPV Vaccine Perceptions. Table 4 summarizes the participants' HPV and HPV vaccine perceptions. HPV vaccine effectiveness perception items (n = 3) were correlated significantly and comprised the HPV vaccine effectiveness perception scale (α = 0.76). Table 5 provides the correlation coefficients of HPV vaccine effectiveness perceptions. Additionally, HPV vaccine harm perception items (n = 5) were correlated significantly and comprised the HPV vaccine harm perception scale (α = 0.97). Table 6 provides the correlation coefficients for HPV vaccine harm perceptions. Analyses showed that income had a significant positive correlation with participants feeling like they are good guardians if they get their child the HPV vaccine (p = 0.047) and with being encouraged to get their child the HPV vaccine (p = 0.014). All other relationships were found to be insignificant. A regression analysis found that the HPV vaccine harm perception scale had a significant positive correlation with the perception that the HPV vaccine would cause their child to become more sexually active (p = 0.011). Also, an analysis found that higher scores on the HPV vaccine harm perception scale (β = -0.451) significantly predicted lower scores on the HPV vaccine effectiveness perception scale, explaining 38.5% of the variance (R = 0.620; F [1, 57] = 35.63; p < 0.0001). Furthermore, an analysis of variance showed that the effect of region on participants' perception of HPV vaccine inconvenience for their children was significant (F [6, 80) = 2.96; p = 0.012; see Table 7 for means).
Source and Social Media Use. About 5% of participants reported that social media was their main source of information about HPV and the HPV vaccine; however, healthcare providers were still the main source of information in both cases. Figures 1 and 2 provide summaries.
Most participants reported using social media, specifically a Facebook account (Figure 3) . HPV/HPV VACCINE AND SOCIAL MEDIA continued. Forty participants (42.1%) indicated that they follow health-related pages on social media. Related to social media use and HPV, most (n = 57, 60.0%) had seen information about HPV, 20 participants (21.1%) searched for information, and 15 (15.8%) posted or shared information. Concerning the HPV vaccine and social media, most participants had seen information about the vaccine (n = 56, 58.9%), 15 (15.8%) had searched for information, and 14 (14.7%) had posted information to social media. When asked on a 5-point Likert scale (recoded -2 = "always against," 2 = "always in favor"), participants did not perceive that social media was significantly in favor or against the HPV vaccine (n = 55, M = 0.00, SD = 1.20, t(54) = 0.00, p = 1.00).
HPV/HPV VACCINE AND SOCIAL MEDIA continued.
Perceptions of HPV and HPV Vaccine Social Media Messages.
Of the 95 respondents, 55 (57.9%) indicated seeing information about HPV and the HPV vaccine on social media. Table 8 provides summaries of these participants' characteristics. HPV/HPV VACCINE AND SOCIAL MEDIA continued. Table 9 summarizes participant perceptions of social media messages about HPV and the HPV vaccine. Social media-based HPV vaccine effectiveness perception items (n = 3) were correlated significantly and comprised the social media-based HPV vaccine effectiveness perception scale (α = 0.90). Table 10 provides the correlation coefficients of social media-based HPV vaccine effectiveness perceptions. Additionally, social media-based HPV vaccine harm perception items (n = 5) were correlated significantly and comprised the social media-based HPV vaccine harm perception scale (α = 0.96). Table 11 provides the correlation coefficients for social media-based HPV vaccine harm perceptions. When comparing personal perceptions to perceptions of social media messages, personal context scores were significantly higher for HPV causing warts and cancer, HPV vaccine harm, HPV vaccine discouragement, and HPV vaccine encouragement. Personal context scores were significantly lower for HPV vaccine encouraging increased sexual activity of child (Table 12) .
When participants were grouped by whether they reported seeing information about HPV on social media, there were no significant differences between groups on how they scored on HPV-related items. Concerning perceptions about the HPV vaccine, a one-sample t-test analyzed if what they read on social media increases or decreases their fear about getting their child the HPV vaccine (-1 = decreases, 0 = neither increases nor increases, and 1 = increases). Results indicated that participants perceived that their fears were neither significantly increased or decreased by social media (M = 0.11, SD = 0.50; t(54) = 1.63, p = 0.109). Participants who had reported seeing information on social media about the HPV vaccine (M= 2.50, SD = 1.62) were significantly more likely to perceive that the HPV vaccine could kill their child than those who had not seen information (M = 1.74, SD = 0.85; t(79) = 0.019). All other tests found relationships to be statistically insignificant.
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DISCUSSION
This study suggested that social media may have a negative influence on Kansas guardian perceptions of the HPV vaccine. While guardians who reported seeing information about the HPV vaccine on social media perceived a divided climate and were not being influenced by it, they were significantly more likely to believe that the HPV vaccine can kill their child. This is aligned with findings that exposure to negative social media messages about the HPV vaccine can lead to audiences holding negative perceptions. 15, 16 The idea of parents fearing vaccines is also not a completely new concept. A survey of U.S. adults found that 32% believe that the risks of childhood vaccine side effects are "medium" or "high". 26 Guardians appear to take the threat of HPV, in terms of causing cancer and genital warts, seriously. The participants believed their perceptions of HPV risks to be stronger than social media depictions. However, Kansas guardians also believed that their perceptions of the HPV vaccine's potential to cause harm to their children were also stronger than social media depictions.
Healthcare providers are the dominant primary source for information about HPV and the HPV vaccine. While a small percentage of guardians reported that social media is their main source of information about HPV and the HPV vaccine, most participants reported seeing information about these topics on social media. This result further suggested that social media is influencing many Kansas guardians about the HPV vaccine. Future efforts to increase HPV vaccination rates among Kansas children may best be directed at addressing social media messaging, guardians' fears about the HPV vaccine killing their children, and HPV vaccine effectiveness, rather than the threat that HPV poses.
The study suggested that, even though vaccination can begin as early as age 9, Kansas guardians are waiting until their children are teenagers before getting them the HPV vaccine. Regionally, guardians residing in South Central and North Central Kansas, mostly rural areas, perceived the vaccine as inconvenient. The CDC reported that adolescents in rural areas trail urban adolescents in HPV vaccination rates. 27 Future research can analyze inconvenience factors that particularly address rural citizens and perceptions of the HPV vaccine. Furthermore, children of guardians with an annual household income of under $100,000 are more likely to not receive the HPV vaccine. This is contrary to national reports, where adolescents above the poverty line trail those who are below it for HPV vaccination rates. 28 For wealthier guardians, being encouraged to get their children vaccinated and feeling like they are good parents for doing so, appeared to have a role in the higher vaccination rates among their children. Future research with larger, representative, and non-convenience samples exploring guardian reasons for delayed HPV vaccination, lower vaccination rates among lower socioeconomic groups, and comparing Kansas with other regions can enhance understanding of and improve HPV vaccination uptake among children in Kansas.
CONCLUSION
This study showcased the perceptions that Kansas guardians of children ages 9 -17 have about HPV and the HPV vaccine, their perceptions of how HPV and the HPV vaccine are represented on social media, and the potential influence that social media has on their perceptions. Given the ubiquity of social media and the pervasiveness of HPV and HPV vaccine messages, its potential effects should not be ignored. Continued research and efforts to understand and harness the power of social media on the HPV vaccine are needed, specifically fear and acceptance, among Kansas guardians. These efforts are necessary to increase vaccination uptake among their children, thereby reducing the future HPV-related disease burden.
